Skip to main content
. Author manuscript; available in PMC: 2013 Jun 7.
Published in final edited form as: J Thorac Oncol. 2010 Nov;5(11):1835–1840. doi: 10.1097/JTO.0b013e3181f0bd78

Table 4.

Adverse Events by Platinum Sensitivity

Platinum sensitive
(n=38)
Platinum refractory
(n=44)
Grade
Grade
ADVERSE EVENT 2 3 4 5 2 3 4 5


Allergy/immunology 0 0 0 0 1 1 0 0
Blood/Bone Marrow 2 0 0 0 2 1 0 0
Cardiac General 3 3 0 0 3 0 0 0
Coagulation 0 1 0 0 0 1 0 0
Constitutional symptoms 12 4 1 0 15 5 0 0
Dermatology/Skin 11 11 0 0 14 11 0 0
Gastrointestinal 17 2 0 0 16 3 1 0
Hepatobiliary/Pancreas 0 0 0 0 0 0 0 1
Infection 1 1 0 0 1 1 0 0
Metabolic/Laboratory 2 4 0 0 2 4 1 0
Musculoskeletal/Soft Tissue 1 0 0 0 2 1 0 0
Neurology 6 2 1 0 1 3 0 0
Pain 6 3 0 0 3 4 0 0
Pulmonary/Upper Respiratory 1 2 1 0 3 1 0 0
MAXIMUM GRADE ANY ADVERSE EVENT
Number 10 23 1 0 15 20 2 1